POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,675 | -93.0% | 1,124 | -94.8% | 0.00% | – |
| Q2 2023 | $38,210 | -90.1% | 21,710 | -82.6% | 0.00% | – |
| Q1 2023 | $385,120 | -55.6% | 125,039 | -23.6% | 0.00% | -100.0% |
| Q4 2022 | $867,478 | +8574.8% | 163,675 | +5651.1% | 0.00% | – |
| Q3 2022 | $10,000 | +150.0% | 2,846 | +103.0% | 0.00% | – |
| Q2 2022 | $4,000 | -76.5% | 1,402 | -62.7% | 0.00% | – |
| Q1 2022 | $17,000 | -72.6% | 3,757 | -58.5% | 0.00% | – |
| Q4 2021 | $62,000 | +29.2% | 9,060 | +36.3% | 0.00% | – |
| Q3 2021 | $48,000 | -18.6% | 6,645 | +11.9% | 0.00% | – |
| Q2 2021 | $59,000 | +84.4% | 5,937 | +76.0% | 0.00% | – |
| Q1 2021 | $32,000 | -33.3% | 3,373 | -23.4% | 0.00% | – |
| Q4 2020 | $48,000 | +700.0% | 4,405 | +582.9% | 0.00% | – |
| Q3 2020 | $6,000 | – | 645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $9,254,000 | 2.96% |
| SECTORAL ASSET MANAGEMENT INC | 1,053,779 | $9,347,000 | 0.80% |
| Pentwater Capital Management LP | 4,879,490 | $43,281,000 | 0.56% |
| Vivo Capital, LLC | 926,449 | $8,218,000 | 0.48% |
| Boxer Capital, LLC | 1,251,055 | $11,097,000 | 0.38% |
| Ikarian Capital, LLC | 228,000 | $2,022,000 | 0.15% |
| Perceptive Advisors | 787,745 | $6,987,000 | 0.10% |
| Rock Springs Capital Management LP | 367,499 | $3,260,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 148,949 | $1,321,000 | 0.07% |
| PIPER SANDLER & CO. | 8,298 | $74,000 | 0.06% |